|
ATCC
escherichia coli Escherichia Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/escherichia coli/product/ATCC Average 99 stars, based on 1 article reviews
escherichia coli - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
25922 atcc 27853 atcc 13883 antibiotic content evaluation inhibitor 25922 Atcc 27853 Atcc 13883 Antibiotic Content Evaluation Inhibitor, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/25922 atcc 27853 atcc 13883 antibiotic content evaluation inhibitor/product/ATCC Average 99 stars, based on 1 article reviews
25922 atcc 27853 atcc 13883 antibiotic content evaluation inhibitor - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
i escherichia coli i atcc I Escherichia Coli I Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/i escherichia coli i atcc/product/ATCC Average 99 stars, based on 1 article reviews
i escherichia coli i atcc - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
bacteria Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bacteria/product/ATCC Average 99 stars, based on 1 article reviews
bacteria - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
escherichia coli gfp atcc atcc 25922gfp staphylococcus aureus atcc atcc Escherichia Coli Gfp Atcc Atcc 25922gfp Staphylococcus Aureus Atcc Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/escherichia coli gfp atcc atcc 25922gfp staphylococcus aureus atcc atcc/product/ATCC Average 97 stars, based on 1 article reviews
escherichia coli gfp atcc atcc 25922gfp staphylococcus aureus atcc atcc - by Bioz Stars,
2026-03
97/100 stars
|
Buy from Supplier |
|
ATCC
e coli atcc 25922 ![]() E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/e coli atcc 25922/product/ATCC Average 99 stars, based on 1 article reviews
e coli atcc 25922 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
pathogenic bacterial strains ![]() Pathogenic Bacterial Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pathogenic bacterial strains/product/ATCC Average 99 stars, based on 1 article reviews
pathogenic bacterial strains - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
bacterial strains ![]() Bacterial Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bacterial strains/product/ATCC Average 95 stars, based on 1 article reviews
bacterial strains - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
ATCC
k pneumoniae atcc ![]() K Pneumoniae Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/k pneumoniae atcc/product/ATCC Average 99 stars, based on 1 article reviews
k pneumoniae atcc - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
Image Search Results
Journal:
Article Title: MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels
doi: 10.1128/AAC.00166-09
Figure Lengend Snippet: Relative amounts of UDP-MurNAc-tripeptide and -pentapeptide in E. coli OC2530 overexpressing MurF a
Article Snippet: In contrast, cycloserine was more potent than DQ1 against wild-type E. coli (MICs, 16 to 32 μg/ml) and displayed activity (MICs, 32 to 128 μg/ml) against the strains of gram-positive bacteria tested. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1. caption a7 Structures of the MurF inhibitors DQ1 and DQ2. table ft1 table-wrap mode="anchored" t5 TABLE 1. caption a7 Strain MIC (μg/ml) DQ1 DQ1 plus 2 μg/ml PMBN PMBN only DQ2 Cycloserine E. coli OC2530 (LPS defective) 8 2 16 8 64 E. coli OC2605 >32 4 32 >32 16 E. coli OC9040 >32 8 64 >32 32
Techniques: Control
Journal:
Article Title: MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels
doi: 10.1128/AAC.00166-09
Figure Lengend Snippet: Susceptibilities of bacterial strains to MurF inhibitors DQ1 and DQ2
Article Snippet: In contrast, cycloserine was more potent than DQ1 against wild-type E. coli (MICs, 16 to 32 μg/ml) and displayed activity (MICs, 32 to 128 μg/ml) against the strains of gram-positive bacteria tested. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1. caption a7 Structures of the MurF inhibitors DQ1 and DQ2. table ft1 table-wrap mode="anchored" t5 TABLE 1. caption a7 Strain MIC (μg/ml) DQ1 DQ1 plus 2 μg/ml PMBN PMBN only DQ2 Cycloserine E. coli OC2530 (LPS defective) 8 2 16 8 64 E. coli OC2605 >32 4 32 >32 16 E. coli OC9040 >32 8 64 >32 32
Techniques:
Journal:
Article Title: MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels
doi: 10.1128/AAC.00166-09
Figure Lengend Snippet: (A) Growth curves of E. coli OC2530 treated with DQ1. DQ1 was added to mid-logarithmic-phase cultures at 0.5× MIC (diamonds), 1× MIC (circles), 2× MIC (triangles), or 4× MIC (solid squares); and the OD was monitored. The growth curves of a control (to which DMSO was added; solid line) and a cycloserine-treated culture (2× MIC; open squares) are also shown. Aliquots of the cultures were removed for quantitation of CFU at 30 min (B) and 3 h (C).
Article Snippet: In contrast, cycloserine was more potent than DQ1 against wild-type E. coli (MICs, 16 to 32 μg/ml) and displayed activity (MICs, 32 to 128 μg/ml) against the strains of gram-positive bacteria tested. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1. caption a7 Structures of the MurF inhibitors DQ1 and DQ2. table ft1 table-wrap mode="anchored" t5 TABLE 1. caption a7 Strain MIC (μg/ml) DQ1 DQ1 plus 2 μg/ml PMBN PMBN only DQ2 Cycloserine E. coli OC2530 (LPS defective) 8 2 16 8 64 E. coli OC2605 >32 4 32 >32 16 E. coli OC9040 >32 8 64 >32 32
Techniques: Control, Quantitation Assay
Journal:
Article Title: MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels
doi: 10.1128/AAC.00166-09
Figure Lengend Snippet: Microscopy of E. coli OC2530 incubated for 5 h without DQ1 (A and C) and with 0.5× MIC of DQ1 (B and D). (A and B) light microscopy; (C and D) TEM.
Article Snippet: In contrast, cycloserine was more potent than DQ1 against wild-type E. coli (MICs, 16 to 32 μg/ml) and displayed activity (MICs, 32 to 128 μg/ml) against the strains of gram-positive bacteria tested. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1. caption a7 Structures of the MurF inhibitors DQ1 and DQ2. table ft1 table-wrap mode="anchored" t5 TABLE 1. caption a7 Strain MIC (μg/ml) DQ1 DQ1 plus 2 μg/ml PMBN PMBN only DQ2 Cycloserine E. coli OC2530 (LPS defective) 8 2 16 8 64 E. coli OC2605 >32 4 32 >32 16 E. coli OC9040 >32 8 64 >32 32
Techniques: Microscopy, Incubation, Light Microscopy
Journal:
Article Title: MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels
doi: 10.1128/AAC.00166-09
Figure Lengend Snippet: Relative amounts of UDP-MurNAc-tripeptide and -pentapeptide at different concentrations of MurF inhibitors DQ1 and DQ2
Article Snippet: In contrast, cycloserine was more potent than DQ1 against wild-type E. coli (MICs, 16 to 32 μg/ml) and displayed activity (MICs, 32 to 128 μg/ml) against the strains of gram-positive bacteria tested. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG. 1. caption a7 Structures of the MurF inhibitors DQ1 and DQ2. table ft1 table-wrap mode="anchored" t5 TABLE 1. caption a7 Strain MIC (μg/ml) DQ1 DQ1 plus 2 μg/ml PMBN PMBN only DQ2 Cycloserine E. coli OC2530 (LPS defective) 8 2 16 8 64 E. coli OC2605 >32 4 32 >32 16 E. coli OC9040 >32 8 64 >32 32
Techniques: Control